Artificial Intelligence Could Identify Prostate Cancer Patients Likely to Relapse After Surgery, Study Reports

Artificial Intelligence Could Identify Prostate Cancer Patients Likely to Relapse After Surgery, Study Reports
A pathology test that uses artificial intelligence could be used to examine prostate cancer samples and predict which patients are likely to relapse after surgery, a study shows. The test, called Precise MD post-op, is for patients whose disease has not yet metastasized, or spread to distant regions of the body. It automates a commonly used grading system for prostate cancer prognosis, called the Gleason score, by combining morphological and biomarker data into complex algorithms. “By refining diagnoses, we can guide patients toward the best treatment option and optimize care,” senior author Carlos Cordon-Cardo, MD, PhD, chair of the Department of Pathology at the Mount Sinai Health System and professor o
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *